Press release
Smart diagnosis to capture the Intravenous Immunoglobulin Market, reaching US$ 25,884 Million in 2032
Intravenous immunoglobulin (IVIG) is a blood product made up of antibodies that are extracted from healthy donors. It is used to treat a range of conditions including immune deficiencies, autoimmune diseases, and neurological disorders. IVIG is administered via intravenous infusion, and it works by providing the recipient with a boost of antibodies to help fight off infections and other health issues. The global market for IVIG is expected to experience significant growth in the coming years due to a rising incidence of immune system disorders and an increasing demand for biologic therapies.Market Overview:
The global intravenous immunoglobulin market is likely to reach a market value of US$ 12,000 Million in 2022 and is expected to accumulate a market value of US$ 25,884 Million by registering a CAGR of 7.9% in the forecast period 2022-2032. Growth of the intravenous immunoglobulin market can be attributed to the fact that it is the only available treatment option for treatment. The market for intravenous immunoglobulin registered a CAGR of 5% in the historical period 2016-2021
Request For Free Sample Report of Intravenous Immunoglobulin (IVIg) Market @ https://www.persistencemarketresearch.com/samples/2830
Key Players:
Biotest AG
Baxter International Inc.
Octapharma AG
LFB Biotechnologies
Grifols SA
CSL Behring
China Biologics Products Inc.
Kedrion Biopharma
BDI Pharma Inc.
Pfizer Inc.
Drivers and Restraints:
The intravenous immunoglobulin market is influenced by various drivers and restraints. On the one hand, the increasing prevalence of immunodeficiency disorders, such as primary immunodeficiency diseases (PIDD), and autoimmune diseases, including multiple sclerosis, and chronic inflammatory demyelinating polyneuropathy (CIDP), are driving the demand for intravenous immunoglobulin products. Moreover, advancements in the production process and the availability of plasma-derived and recombinant immunoglobulin products are boosting the market growth. On the other hand, the high cost of these therapies and their adverse effects, including thrombotic events and renal dysfunction, are restraining the market growth. Additionally, the shortage of plasma supply and stringent regulatory requirements for the manufacturing and distribution of intravenous immunoglobulin products are also affecting the market growth.
For critical insights on this market, request for customization here@ https://www.persistencemarketresearch.com/request-customization/2830
Related Reports:
Biosimulation Market
https://www.persistencemarketresearch.com/market-research/biosimulation-market.asp
Medical Oxygen Systems Market
https://www.persistencemarketresearch.com/market-research/medical-oxygen-systems-market.asp
Pyrogen Testing Market
https://www.persistencemarketresearch.com/market-research/pyrogen-testing-market.asp
Neurosurgery Market
https://www.persistencemarketresearch.com/market-research/neurosurgery-market.asp
Contact us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
About Us:
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Smart diagnosis to capture the Intravenous Immunoglobulin Market, reaching US$ 25,884 Million in 2032 here
News-ID: 3022823 • Views: …
More Releases from Persistence Market Research
Hot Sauce Market Size US$7.6Bn by 2033 Driven by Rising Demand and Flavor Trends
The global hot sauce market is witnessing strong momentum, driven by evolving consumer taste preferences, rising demand for bold and ethnic flavors, and the growing influence of global food culture. The market is likely to be valued at US$ 4.8 billion in 2026 and is projected to reach approximately US$ 7.6 billion by 2033, expanding at a healthy compound annual growth rate (CAGR) of 6.7% during the forecast period from…
Plant-Based Pet Food Market to Hit US$1,063.8 Mn by 2033 Driven by Health Trends
The global plant-based pet food market is emerging as a high-growth segment within the broader pet care and animal nutrition industry, driven by shifting consumer values, rising pet humanization trends, and increasing awareness of sustainability and ethical sourcing. The market is expected to be valued at US$ 567.2 million in 2026 and is projected to reach approximately US$ 1,063.8 million by 2033, expanding at a robust compound annual growth rate…
Canned Tuna Market Value to Reach US$15.1 Bn by 2033 Driven by Convenience Deman …
The global canned tuna market is poised for consistent growth over the forecast period, supported by rising consumer preference for convenient, affordable, and protein-rich food products. The market is expected to be valued at US$ 10.8 billion in 2026 and is projected to reach approximately US$ 15.1 billion by 2033, expanding at a compound annual growth rate (CAGR) of 4.9% between 2026 and 2033. This positive outlook reflects the canned…
Egg White Substitute Market to Reach US$ 2.3 Bn by 2033 Driven by Vegan Demand
The global egg white substitute market is emerging as a high-growth segment within the broader food ingredients and alternative protein industry, driven by shifting consumer preferences, dietary restrictions, and advancements in food formulation technologies. The market is expected to be valued at US$ 1.5 billion in 2026 and is projected to reach approximately US$ 2.3 billion by 2033, reflecting a compound annual growth rate (CAGR) of 6.2% during the forecast…
More Releases for Intravenous
Rising Cancer Prevalence Driving The Intravenous Solutions Market: Critical Driv …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Intravenous Solutions Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for intravenous solutions has experienced robust expansion recently and is projected to increase from $14 billion in 2024 to $14.91 billion in 2025, reflecting a compound annual growth rate of 6.5%; this upward…
Future Outlook of the Soliris Intravenous Market: Soliris Intravenous Trends and …
The global Soliris Intravenous Market was valued at approximately USD 3.5 billion in 2024 and is projected to reach around USD 6.8 billion by 2033, growing at a compound annual growth rate (CAGR) of about 7.5% from 2025 to 2033.
Request a sample copy of this report at: https://www.omrglobal.com/request-sample/soliris-intravenous-market
Soliris Intravenous Market Overview:
The Soliris Intravenous Market is experiencing steady growth driven by the increasing prevalence of rare and chronic diseases such as…
Intravenous Iron Drugs Market
The "Intravenous Iron Drugs Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Intravenous Iron Drugs Market, 2024-2031
Verified Market Research's most recent report, "Intravenous Iron Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides…
Intravenous (IV) Solutions Market
The Global Intravenous (IV) Solution Market is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022. The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer.
Key Finding
The global Intravenous (IV) Solution market and is expected to reach USD…
Intravenous Solutions Market Opportunity Analysis, 2026
Intravenous solutions are the chemically prepared fluids, which are administered in the body through venous circulation to maintain or replace the lost body fluid level. There are various types of IV solutions that have different effects on a human body. Majority of intravenous solutions constitute of solvent and solute out of which solvents are sterile water and solutes are electrolytes such as sodium, potassium, and chloride. Intravenous solutions market is…
Intravenous Product Packaging Market -
Global healthcare sector continues to develop at an impressive rate. As a result, packaging marketplace is undergoing huge changes with specialized focus on offering innovative packaging tools/products to pharmaceutical industry. One such core product that offers lucrative market opportunities for packaging companies is intravenous products.
Download PDF Brochure For Future Advancements@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14075
Intravenous product such as catheters and IV fluid bags are mainly used to prevent and treat various chronic illness…
